Institut Català d'Oncologia Badalona

Badalona, Barcelona 8916

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Adjuvant, Carcinoma, Transitional Cell, Chronic Myelomonocytic Leukemia, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, Lymphoma, Non-Hodgkin, Myelodysplastic Syndrome/Neoplasm, Myelodysplastic Syndromes, NSCLC, Stage IB-IIIA

Studies at this site

• A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed